Immediate Impact
1 by Nobel laureates 50 standout
Citing Papers
Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors
2024 Standout
Neoadjuvant Chemoimmunotherapy for NSCLC
2024 Standout
Works of Mutlu Doğan being referenced
Endpoints in oncology clinical trials.
2018
Assessment of Prognostic Value of "Neutrophil to Lymphocyte Ratio" and "Prognostic Nutritional Index" as a Sytemic Inflammatory Marker in Non-small Cell Lung Cancer
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Mutlu Doğan | 263 | 122 | 35 | 82 | 77 | 505 | |
| Berta Sousa | 221 | 147 | 34 | 67 | 52 | 540 | |
| M Lucchesi | 201 | 133 | 23 | 73 | 68 | 555 | |
| Tarık Salman | 290 | 99 | 35 | 102 | 65 | 545 | |
| Umut Varol | 367 | 89 | 25 | 83 | 53 | 541 | |
| Jakub Kucharz | 221 | 166 | 41 | 97 | 46 | 542 | |
| Eugene Moylan | 329 | 107 | 49 | 53 | 33 | 529 | |
| Georges Chahine | 234 | 134 | 41 | 44 | 71 | 440 | |
| Hina Saeed | 193 | 97 | 14 | 44 | 43 | 495 | |
| Hisashi Tanaka | 258 | 278 | 19 | 39 | 66 | 499 | |
| Bryce D. Beutler | 197 | 98 | 64 | 95 | 84 | 546 |
All Works
Login with ORCID to disown or claim papers
Loading papers...